Veritas Archives | Follow The Money Investor Group

3 Carbon Extractions Enters into Collaboration with CannabisWise Accreditation

Sept. 13, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that 3 Carbon Extractions Inc. (“3 CARBON”), an industry leader in regulatory compliant cannabis hydrocarbon extraction solutions, has entered into a collaboration with CannabisWise to provide expert advice on standards for cannabis extracts.

Veritas Welcomes MOU Between 3 Carbon Extractions and Rubikon Blockchain VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that 3 Carbon Extractions Inc. (“3 CARBON”), an industry leader in regulatory compliant cannabis hydrocarbon extraction solutions, has entered into…

Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with IsCann Group Limited (“IsCann”) located in Be'er Tuvya, Israel…

Veritas Pharma subsidiary to start trials in Q3

Earlier this year, Veritas Pharma's subsidiary, Cannevert Therapeutics, signed an agreement with Puerto Rico's Fundacion de Investigacion clinical research to perform trials of its lead cannabis strain, CTL-X, to target pain. The anticipated approvals were expected to come at the end of the first quarter of 2018 with a potential start this Q2 2018. Challenges arose with the importation of placebo cannabis from a non-United States supplier. The designated placebo is a cannabis plant material which resembles C

Tag Archives: Veritas